Literature DB >> 17411787

Web-based results distribution: new channels of communication from radiologists to patients.

Annette J Johnson1, Hugh Hawkins, Kimberly E Applegate.   

Abstract

Radiologists face substantial challenges in the timely and appropriate communication of diagnostic test results. As with other systems in health care delivery, the radiology reporting system is not designed to be optimally safe, timely, and patient centered. To improve the quality of care, there must be a new commitment to organizing services around patients' needs, including the reporting of diagnostic test results directly from radiologists to patients. The rationale for this change is that if both referring physicians and patients are given imaging examination results from radiologists immediately after their interpretation, it would be less likely that important diagnostic information would be lost or overlooked. The results would be provided to all stakeholders in a more timely fashion, the potential for important information to "fall through the cracks" would be diminished, and safety would be improved. Providing these results to patients directly online would also allow radiologists to facilitate increased patient satisfaction and patient-centered care by treating patients as "co-customers" and equal partners with referring physicians with regard to access to information and shared decision making.

Entities:  

Mesh:

Year:  2005        PMID: 17411787     DOI: 10.1016/j.jacr.2004.06.018

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  2 in total

Review 1.  The Empirical Foundations of Teleradiology and Related Applications: A Review of the Evidence.

Authors:  Rashid L Bashshur; Elizabeth A Krupinski; James H Thrall; Noura Bashshur
Journal:  Telemed J E Health       Date:  2016-09-01       Impact factor: 3.536

2.  Radiology and patient communication: if not now, then when?

Authors:  Julie Cox; Yitka Graham
Journal:  Eur Radiol       Date:  2019-07-29       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.